Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Pegcrisantaspase |
Synonyms | |
Therapy Description |
Pegcrisantaspase is a recombinant PEGylated asparaginase derived from Erwinia chrysanthemi, which potentially inhibits cell proliferation and tumor growth (PMID: 29090524, Cancer Res 2020;80(16 Suppl):Abstract nr 4047). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Pegcrisantaspase | Pegcrisantaspase is a recombinant PEGylated asparaginase derived from Erwinia chrysanthemi, which potentially inhibits cell proliferation and tumor growth (PMID: 29090524, Cancer Res 2020;80(16 Suppl):Abstract nr 4047). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|